Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study to track MUSE stem cell therapy in TBI patients seeking treatment abroad

NCT ID NCT07326059

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 30 times

Summary

This study follows 10 people aged 6 to 75 with chronic traumatic brain injury who choose to get MUSE stem cell therapy outside the U.S. Researchers will watch for side effects and track changes in brain function, quality of life, and daily activities over 12 months. No treatment is given by the study—it only collects information to learn more about this experimental therapy's real-world safety and benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Healing Hope International

    Houston, Texas, 77386, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Stem Solutions

    Monterrey, Nuevo León, 66278, Mexico

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.